Moderna reports early success with COVID vaccine in children under 6
Moderna has announced the first data from a trial testing its COVID-19 vaccine in children under the age of six. The results show similar antibody responses after two doses to those seen in adults. Moderna plans to apply for FDA authorization soon. Source of Article